DEXAMETHASONE SODIUM PHOS (PF) (dexamethasone sodium phosphate/PF)
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+60
FRESENIUS KABI
Indication
Asthma exacerbation
An asthma exacerbation is an acute or subacute episode of progressively worsening respiratory impairment occurring in pediatric or adult patients with preexisting asthma. Read more about Asthma exacerbation
197 drugs 125 manufacturers
Drugs that treat it
Common Asthma exacerbation therapies.
DEXABLISS (dexamethasone)
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
LEVINS PHARMACE
ZCORT (dexamethasone)
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
SCITE PHARMA, L
RAYOS (prednisone)
PULMONARY TUBERCULOSIS·+67
HORIZON THERAPE
MILLIPRED (prednisolone)
TRICHINOSIS·+59
AVALO THERAPEUT
DOUBLEDEX (PF) (dexamethasone sodium phosphate/PF)
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+60
ENOVACHEM MANUF
ACTIVE INJECTION KIT D (PF) (dexamethasone sodium phosphate/PF)
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+60
PHARMACEUTICA N
MAS CARE-PAK (PF) (dexamethasone sodium phosphate/PF)
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+60
MAS MANAGEMENT
PREDNISOLONE
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+59
PHARMACEU ASSOC
Filter & compare in the drug finder →Opens the drug finder with Asthma exacerbation preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAn asthma exacerbation is an acute or subacute episode of progressively worsening respiratory impairment occurring in pediatric or adult patients with preexisting asthma.
It involves the lower respiratory tract and is driven pathophysiologically by heightened airway inflammation, acute bronchospasm, mucosal edema, and increased mucus hypersecretion.
Clinically, this episode is characterized by escalating dyspnea, wheezing, cough, and chest tightness, accompanied by an objective decrease from baseline in expiratory airflow metrics such as peak expiratory flow or forced expiratory volume in one second.
- nih.gov
An asthma exacerbation is an acute or subacute episode of progressively worsening respiratory impairment occurring in pediatric or adult patients with preexisting asthma Clinically, this episode is characterized by escalating dyspnea, wheezing, cough, and chest tightness, accompanied by an objective decrease from baseline in expiratory airflow metrics such as peak expiratory flow or forced expiratory volume in one second
- nih.gov
It involves the lower respiratory tract and is driven pathophysiologically by heightened airway inflammation, acute bronchospasm, mucosal edema, and increased mucus hypersecretion
- ginasthma.org
It involves the lower respiratory tract and is driven pathophysiologically by heightened airway inflammation, acute bronchospasm, mucosal edema, and increased mucus hypersecretion Clinically, this episode is characterized by escalating dyspnea, wheezing, cough, and chest tightness, accompanied by an objective decrease from baseline in expiratory airflow metrics such as peak expiratory flow or forced expiratory volume in one second
- nih.gov
Clinically, this episode is characterized by escalating dyspnea, wheezing, cough, and chest tightness, accompanied by an objective decrease from baseline in expiratory airflow metrics such as peak expiratory flow or forced expiratory volume in one second
Personalize your experience
Follow Asthma exacerbation and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.